Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients

NCT06043531 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT06043531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06043531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Trimethylamine N-Oxide for Cardiovascular Health In Liver Transplant Recipients
Lead sponsor
Virginia Commonwealth University
Phase
Not applicable
Overall status
Completed
Start date
January 18, 2024
Completion date
October 25, 2024
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant